echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Haisco: Phase III clinical trial of cyclopofol injection received ethical approval

    Haisco: Phase III clinical trial of cyclopofol injection received ethical approval

    • Last Update: 2021-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 7th, Haisco announced that the Phase III clinical trial of the innovative drug cyclopofol injection has been ethically approved


    The indications currently on the market for cyclopofol injection include sedation in gastrointestinal endoscopy and induction of general anesthesia, and the indications that have been submitted for marketing applications include sedation and/or anesthesia for bronchoscopy diagnosis and treatment, and induction and maintenance of general anesthesia


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.